BLASTOID-FERTILITY Human Blastoid-Based Platform for Post-Implantation IVF Optimization and Therapeutic Screening
- Coordinator
- Institut Fuer Molekulare Biotechnologie GmbH, Austria
- Runs
- 1 October 2026 to 31 March 2028
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101292866
What the project is doing
In the project's own words, from its summary on CORDIS.
Since the first successful IVF birth in 1978, the technology has become a cornerstone of assistedreproduction, driven by the trend toward delayed parenthood. While IVF now accounts for roughly5% of births in Europe, its overall efficiency remains low, with only about 25% of cycles resulting in alive birth. A major bottleneck is the high rate of failure during implantation. Due to the limitedavailability of human embryos and ethical restrictions, IVF optimization has historically relied onmouse models.
However, while pre-implantation development is similar between mice and humans,their post-implantation trajectories diverge significantly, limiting their translational relevance. Thishighlights the urgent need for a reliable, ethical, and predictive model of early human developmentafter implantation. Under the ERC-CoG program, we developed human blastoids, blastocyst-likestructures that accurately mimic key features of pre-implantation human embryogenesis.
The present ERC-PoC project will translatethis platform into a pre-commercial application by screening compounds to improve IVF outcomes. Our expected deliverables include: (i) a validated blastoid-based screening platform, (ii) patented natural compounds with therapeutic potential for IVF, and (iii) abusiness and IP framework for investors, partners, and funding bodies.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Institut Fuer Molekulare Biotechnologie GmbH | Wien | Austria | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI